Literature DB >> 15906420

Prenatal diagnosis of sickle syndromes in India: dilemmas in counselling.

Roshan Colah1, Reema Surve, Anita Nadkarni, Ajit Gorakshakar, Supriya Phanasgaonkar, Poornima Satoskar, Dipika Mohanty.   

Abstract

OBJECTIVES: The sickle gene is prevalent in the scheduled caste and tribal populations in India. The clinical presentation of sickle cell disease is extremely variable, and there are no neonatal screening programmes. This is the first report on prenatal diagnosis of sickle syndromes in 85 couples at risk (sickle cell anemia-69; sickle thalassemia-16) from different regions in India. Most of the couples were from a low socioeconomic group and their decisions were entirely dependent on the local counselling given. We have evaluated the acceptability of prenatal diagnosis and the dilemmas faced in counselling these families.
METHODS: Chorion villus sampling was done in the first trimester and DNA analysis using reverse dot blot hybridization or restriction enzyme digestion with Dde1 in 65 cases. Cordocentesis was done in the second trimester and fetal blood analyses by automated HPLC in 20 cases who came late.
RESULTS: 32.9% of couples came prospectively for diagnosis. 23.5% of fetuses were affected (sickle cell anemia-18, sickle thalassemia-2). The beta-thalassemia mutation in both cases was IVS 1-5(G->C). All the couples with an unfavourable diagnosis opted for termination of pregnancy.
CONCLUSION: Sickle cell anemia has a relatively benign clinical course in some tribal groups in India. This raises a dilemma whether we are justified in advising prenatal diagnosis in all such cases. Copyright (c) 2005 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2005        PMID: 15906420     DOI: 10.1002/pd.1131

Source DB:  PubMed          Journal:  Prenat Diagn        ISSN: 0197-3851            Impact factor:   3.050


  8 in total

Review 1.  HPLC studies in hemoglobinopathies.

Authors:  R B Colah; R Surve; P Sawant; E D'Souza; K Italia; S Phanasgaonkar; A H Nadkarni; A C Gorakshakar
Journal:  Indian J Pediatr       Date:  2007-07       Impact factor: 1.967

2.  Prenatal diagnosis of sickle cell disease by the technique of PCR.

Authors:  Praneeta J Singh; A C Shrivastava; A V Shrikhande
Journal:  Indian J Hematol Blood Transfus       Date:  2014-07-08       Impact factor: 0.900

3.  Sickle cell anemia--molecular diagnosis and prenatal counseling: SGPGI experience.

Authors:  Ravindra Kumar; Inusha Panigrahi; Ashwin Dalal; Sarita Agarwal
Journal:  Indian J Pediatr       Date:  2011-06-29       Impact factor: 1.967

4.  Sickle cell disease in tribal populations in India.

Authors:  Roshan B Colah; Malay B Mukherjee; Snehal Martin; Kanjaksha Ghosh
Journal:  Indian J Med Res       Date:  2015-05       Impact factor: 2.375

5.  Sickle cell disease: Progress made & challenges ahead.

Authors:  Isaac Odame; Dipty Jain
Journal:  Indian J Med Res       Date:  2020-06       Impact factor: 2.375

Review 6.  Sickle cell disease in India: a scoping review from a health systems perspective to identify an agenda for research and action.

Authors:  Vineet Raman; Prashanth N Srinivas; Tanya Seshadri; Sangeetha V Joice
Journal:  BMJ Glob Health       Date:  2021-02

Review 7.  Evolving locally appropriate models of care for indian sickle cell disease.

Authors:  Graham R Serjeant
Journal:  Indian J Med Res       Date:  2016-04       Impact factor: 2.375

8.  Assessment of Factors Associated with the Effectiveness of Premarital Screening for Hemoglobinopathies in the South of Saudi Arabia.

Authors:  Ibrahim M Gosadi; Gassem A Gohal; Alanoud E Dalak; Anas A Alnami; Norah A Aljabri; Atyaf J Zurayyir
Journal:  Int J Gen Med       Date:  2021-06-30
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.